% | $
Quotes you view appear here for quick access.

Neostem, Inc. Message Board

  • bob_flemings bob_flemings Apr 9, 2013 12:54 PM Flag

    NBS touted and recognized...again

    Nice to see NeoStem being written about by Brian on SA. Rather brief mention, but good:

    NeoStem (NBS)

    In the last month, the $100 million company NeoStem has rallied 25%. This is a company that significantly underperformed its key developments over the last year, but now looks to be pricing in its potential and the fact that data for AMR-001 is just around the corner.

    In the last year the company has found a threshold dose for CD34+ cells, developed VSELs into clinical trials, formed a partnership with the Vatican, grew revenue by 100% in its manufacturing business, and is now very close to full enrollment of its Phase 2 trial, which could significantly change the valuation of this company. The stock is trading above its 50-day moving average and looks to have seen a reversal higher. It will be interesting to follow this stock over the next several weeks to see if it breaks out even higher, a possibility that I think could occur next week.

    Sentiment: Strong Buy

2.250.00(0.00%)Jun 5 3:59 PMEDT